TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness July 24, 1992